BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38216726)

  • 1. Identification of blood metabolites associated with risk of Alzheimer's disease by integrating genomics and metabolomics data.
    Liu S; Zhong H; Zhu J; Wu L
    Mol Psychiatry; 2024 Apr; 29(4):1153-1162. PubMed ID: 38216726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer's risk factors among 1,111 cohort participants.
    Darst BF; Lu Q; Johnson SC; Engelman CD
    Genet Epidemiol; 2019 Sep; 43(6):657-674. PubMed ID: 31104335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
    Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
    Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards understanding brain-gut-microbiome connections in Alzheimer's disease.
    Xu R; Wang Q
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):63. PubMed ID: 27585440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Gut Microbial Metabolites in Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Signals in Host-Microbe Interplay.
    Wu L; Han Y; Zheng Z; Peng G; Liu P; Yue S; Zhu S; Chen J; Lv H; Shao L; Sheng Y; Wang Y; Li L; Li L; Wang B
    Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.
    Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q
    BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of Blood Thiamine Metabolites for Alzheimer's Disease Diagnosis.
    Pan X; Fei G; Lu J; Jin L; Pan S; Chen Z; Wang C; Sang S; Liu H; Hu W; Zhang H; Wang H; Wang Z; Tan Q; Qin Y; Zhang Q; Xie X; Ji Y; Cui D; Gu X; Xu J; Yu Y; Zhong C
    EBioMedicine; 2016 Jan; 3():155-162. PubMed ID: 26870826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between genetically predicted plasma protein levels and Alzheimer's disease risk: a study using genetic prediction models.
    Zhu J; Liu S; Walker KA; Zhong H; Ghoneim DH; Zhang Z; Surendran P; Fahle S; Butterworth A; Alam MA; Deng HW; Wu C; Wu L
    Alzheimers Res Ther; 2024 Jan; 16(1):8. PubMed ID: 38212844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Gut Bacteria Specific to Alzheimer's Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on Human Gut Metagenomics and Metabolomics.
    Paley EL
    J Alzheimers Dis; 2019; 72(1):319-355. PubMed ID: 31561379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mendelian randomization identifies blood metabolites previously linked to midlife cognition as causal candidates in Alzheimer's disease.
    Lord J; Jermy B; Green R; Wong A; Xu J; Legido-Quigley C; Dobson R; Richards M; Proitsi P
    Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33879569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between gut microbiota and Alzheimer's disease, major depressive disorder, and schizophrenia.
    Zhuang Z; Yang R; Wang W; Qi L; Huang T
    J Neuroinflammation; 2020 Oct; 17(1):288. PubMed ID: 33008395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis.
    Li RJ; Jie ZY; Feng Q; Fang RL; Li F; Gao Y; Xia HH; Zhong HZ; Tong B; Madsen L; Zhang JH; Liu CL; Xu ZG; Wang J; Yang HM; Xu X; Hou Y; Brix S; Kristiansen K; Yu XL; Jia HJ; He KL
    Front Cell Infect Microbiol; 2021; 11():708088. PubMed ID: 34692558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis study of the robustness and universality of gut microbiome-metabolome associations.
    Muller E; Algavi YM; Borenstein E
    Microbiome; 2021 Oct; 9(1):203. PubMed ID: 34641974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's disease.
    Martinelli F; Heinken A; Henning AK; Ulmer MA; Hensen T; González A; Arnold M; Asthana S; Budde K; Engelman CD; Estaki M; Grabe HJ; Heston MB; Johnson S; Kastenmüller G; Martino C; McDonald D; Rey FE; Kilimann I; Peters O; Wang X; Spruth EJ; Schneider A; Fliessbach K; Wiltfang J; Hansen N; Glanz W; Buerger K; Janowitz D; Laske C; Munk MH; Spottke A; Roy N; Nauck M; Teipel S; Knight R; Kaddurah-Daouk RF; Bendlin BB; Hertel J; Thiele I
    Sci Rep; 2024 Mar; 14(1):6095. PubMed ID: 38480804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
    Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
    Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Human Blood Metabolome and the Risk of Alzheimer's Disease.
    Sun L; Guo D; Jia Y; Shi M; Yang P; Wang Y; Liu F; Chen GC; Zhang Y; Zhu Z
    Ann Neurol; 2022 Nov; 92(5):756-767. PubMed ID: 35899678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Analysis of the Microbiome and Metabolome in the 5xfAD Mouse Model of Alzheimer's Disease.
    Dunham SJB; McNair KA; Adams ED; Avelar-Barragan J; Forner S; Mapstone M; Whiteson KL
    mBio; 2022 Dec; 13(6):e0179422. PubMed ID: 36468884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations.
    Panyard DJ; Kim KM; Darst BF; Deming YK; Zhong X; Wu Y; Kang H; Carlsson CM; Johnson SC; Asthana S; Engelman CD; Lu Q
    Commun Biol; 2021 Jan; 4(1):63. PubMed ID: 33437055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.